GBM134 GBM Model

GBM134-derived PDX model provides researchers with a robust and reliable platform for screening and evaluating potential drug candidates in Brain Cancer drug discovery. Its unique ability to faithfully replicate the complexity of patient tumors ensures that promising therapies are identified with confidence. GBM134 PDX accelerates the drug development process by offering a realistic representation of patient responses, making it an indispensable tool in the quest for more effective Brain Cancer treatments.

Model Details

Cancer Location: Intracranial
Cancer Type: Brain Cancer
Model Name: GBM134
Mouse Strain: Nu/Nu
Treatment Data Available: Chemotherapy (Temozolomide)
WES: Yes
RNAseq: Yes
Methylation: Yes
PDX Treatment: Yes
Patient Treatment History: Yes

GBM134 Survival

Survival of orthotopic intracranial implanted  GBM134 in Nu/Nu mice  (n=5)

Request Additional GBM Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content